Dosage-dependent non-linear effect of l-dopa on human motor cortex plasticity

Journal of Physiology

Volumn 588, Issue 18, 2010, Pages 3415-3424

  Monte Silva, Katia ^a,b   Liebetanz, David ^a   Grundey, Jessica ^a   Paulus, Walter ^a   Nitsche, Michael A ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BENSERAZIDE; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; PERGOLIDE; PLACEBO; ROPINIROLE;

ADULT; ARTICLE; DIRECT CURRENT; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG MEGADOSE; FEMALE; HUMAN; HUMAN EXPERIMENT; LEARNING; LONG TERM DEPRESSION; LONG TERM POTENTIATION; LOW DRUG DOSE; MALE; MEMORY; MOTOR CORTEX; NAUSEA; NERVE CELL PLASTICITY; NEUROMODULATION; NORMAL HUMAN; PRIORITY JOURNAL; TRANSCRANIAL MAGNETIC STIMULATION; VOMITING;

ADULT; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; LEVODOPA; MALE; MOTOR CORTEX; NEURONAL PLASTICITY; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 77956771665     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2010.190181     Document Type: Article

References (44)

1. Bertolino A, Fazio L, Giorgio A, Blasi G, Romano R, Taurisano P, Caforio G, Sinibaldi L, Ursini G, Popolizio T, Tirotta E, Papp A, Dallapiccola B, Borrelli E, Sadee W. Genetically determined interaction between the dopamine transporter and the D2 receptor on prefronto-striatal activity and volume in humans. J Neurosci 2009, 29:1224-1234.
2. Cai JX, Arnsten AF. Dose-dependent effects of the dopamine D1 receptor agonists A77636 or SKF81297 on spatial working memory in aged monkeys. J Pharmacol Exp Ther 1997, 283:183-189.
3. Calabresi P, Picconi B, Tozzi A, Filippo Di. Dopamine-mediated regulation of corticostriatal synaptic plasticity. Trends Neurosci 2007, 30:211-219.
4. Castro NG, de Mello MC, de Mello FG, Aracava Y. Direct inhibition of the N-methyl-d-aspartate receptor channel by dopamine and (+)-SKF38393. Br J Pharmacol 1999, 126:1847-1855.
5. Cheeran B, Talelli P, Mori F, Koch G, Suppa A, Edwards M, Houlden H, Bhatia K, Greenwood R, Rothwell JC. A common polymorphism in the brain-derived neurotrophic factor gene (BDNF) modulates human cortical plasticity and the response to rTMS. J Physiol 2008, 586:5717-5725.
6. Chen L, Yang CR. Interaction of dopamine D1 and NMDA receptors mediates acute clozapine potentiation of glutamate EPSPs in rat prefrontal cortex. J Neurophysiol 2002, 87:2324-2336.
7. de la Fuente-Fernández R, Sossi V, Huang Z, Furtado S, Lu JQ, Calne DB, Ruth TJ, Stoessl AJ. Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias. Brain 2004, 127:2747-2754.
8. Dingemanse J, Jorga K, Zürcher G, Schmitt M, Sedek G, Da Prada M, Van Brummelen P. Pharmacokinetic-pharmacodynamic interaction between the COMT inhibitor tolcapone and single-dose levodopa. Br J Clin Pharmacol 1995, 40:253-262.
9. Djaldetti R, Giladi N, Hassin-Baer S, Shabtai H, Melamed E. Pharmacokinetics of etilevodopa compared to levodopa in patient's with Parkinson's disease: an open-label, randomized, crossover study. Clin Neuropharmacol 2003, 26:322-326.
10. Flöel A, Breitenstein C, Hummel F, Celnik P, Gingert C, Sawaki L, Knecht S, Cohen LG. Dopaminergic influences on formation of a motor memory. Ann Neurol 2005, 58:121-130.
11. Flöel A, Vomhof P, Lorenzen A, Roesser N, Breitenstein C, Knecht S. Levodopa improves skilled hand functions in the elderly. Eur J Neurosci 2008, 27:1301-1307.
12. Goldman-Rakic PS, Muly EC, Williams GV. D1 receptors in prefrontal cells and circuits. Brain Res Rev 2000, 31:295-301.
13. Islam N, Aftabuddin M, Moriwaki A, Hattori Y, Hori Y. Increase in the calcium level following anodal polarization in the rat brain. Brain Res 1995, 684:206-208.
14. Khor SP, Hsu A. The pharmacokinetics and pharmacodynamics of levodopa in the treatment of Parkinson's disease. Curr Clin Pharmacol 2007, 2:234-243.
15. Knecht S, Breitenstein C, Bushuven S, Wailke S, Kamping S, Floel A, Zwitserlood P, Ringelstein EB. Levodopa: faster and better word learning in normal humans. Ann Neurol 2004, 56:20-26.
16. Kolomiets B, Marzo A, Caboche J, Vanhoutte P, Otani S. Background dopamine concentration dependently facilitates long-term potentiation in rat prefrontal cortex through postsynaptic activation of extracellular signal-regulated kinases. Cereb Cortex 2009, 19:2708-2718.
17. Kotecha SA, Oak JN, Jackson MF, Perez Y, Orser BA, Van Tol HHM, MacDonald JF. A D2 class dopamine receptor transactivates a receptor tyrosine kinase to inhibit NMDA receptor transmission. Neuron 2002, 35:1111-1122.
18. Kung VW, Hassam R, Morton AJ, Jones S. Dopamine-dependent long term potentiation in the dorsal striatum is reduced in the R6/2 mouse model of Huntington's disease. Neuroscience 2007, 146:1571-1580.
19. Kuo MF, Grosch J, Fregni F, Paulus W, Nitsche MA. Focusing effect of acetylcholine on neuroplasticity in the human motor cortex. J Neurosci 2007, 27:14442-14447.
20. Kuo MF, Paulus W, Nitsche MA. Boosting focally-induced brain plasticity by dopamine. Cereb Cortex 2008, 18:648-651.
21. Lang N, Speck S, Harms J, Rothkegel H, Paulus W, Sommer M. Dopaminergic potentiation of rTMS-induced motor cortex inhibition. Biol Psychiatry 2008, 63:231-233.
22. Liebetanz D, Nitsche MA, Tergau F, Paulus W. Pharmacological approach to the mechanisms of transcranial DC-stimulation-induced after-effects of human motor cortex excitability. Brain 2002, 125:2238-2247.
23. Liepert J. Pharmacotherapy in restorative neurology. Curr Opin Neurol 2008, 21:639-643.
24. Lisman JE. Three Ca2+ levels affect plasticity differently: the LTP zone, the LTD zone and no man's land. J Physiol 2001, 532:285.
25. Mattay VS, Goldberg TE, Fera F, Hariri AR, Tessitore A, Egan MF, Kolachana B, Callicott JH, Weinberger DR. Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci U S A 2003, 100:6186-6191.
26. Misonou H, Mohapatra DP, Park EW, Leung V, Zhen D, Misonou K, Anderson AE, Trimmer JS. Regulation of ion channel localization and phosphorylation by neuronal activity. Nat Neurosci 2004, 7:711-718.
27. Morgante F, Espay AJ, Gunraj C, Lang AE, Chen R. Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias. Brain 2006, 129:1059-1069.
28. Monte-Silva K, Kuo M, Thirugnanasambandam N, Liebetanz D, Paulus Walter, Nitsche MA. Dose-dependent inverted U-shaped effect of dopamine (D2-like) receptor activation on focal and non-focal plasticity in humans. J Neurosci 2009, 29:6124-6131.
29. Nitsche MA, Fricke K, Henschke U, Schlitterlau A, Liebetanz D, Lang N, Henning S, Tergau F, Paulus W. Pharmacological modulation of cortical excitability shifts induced by transcranial direct current stimulation in humans. J Physiol 2003b, 553:293-301.
30. Nitsche MA, Grundey J, Liebetanz D, Lang N, Tergau F, Paulus W. Catecholaminergic consolidation of motor cortical neuroplasticity in humans. Cerebral Cortex 2004a, 14:1240-1245.
31. Nitsche MA, Jaussi W, Liebetanz D, Lang N, Tergau F, Paulus W. Consolidation of human motor cortical neuroplasticity by D-cycloserine. Neuropsychopharmacology 2004b, 29:1573-1578.
32. Nitsche MA, Paulus W. Sustained excitability elevations induced by transcranial DC motor cortex stimulation in humans. Neurology 2001, 57:1899-1901.
33. Nitsche MA, Nitsche MS, Klein CC, Tergau F, Rothwell JC, Paulus W. Level of action of cathodal DC polarisation induced inhibition of the human motor cortex. Clin Neurophysiol 2003a, 114:600-604.
34. Nitsche MA, Lampe C, Antal A, Liebetanz D, Lang N, Tergau F, Paulus W. Dopaminergic modulation of long-lasting direct current induced cortical excitability changes in the human motor cortex. Eur J Neurosci 2006, 23:1651-1657.
35. Nitsche MA, Cohen LG, Wassermann EM, Priori A, Lang N, Antal A, Paulus W, Hummel F, Boggio PS, Fregni F, Pascual Leone A. Transcranial direct current stimulation: state of the art 2008. Brain Stimul 2008, 1:206-223.
36. Nitsche MA, Kuo MF, Grosch J, Bergner C, Monte-Silva K, Paulus W. D1-receptor impact on neuroplasticity in humans. J Neurosci 2009, 29:2648-2653.
37. O'Carroll CM, Martin SJ, Sandin J, Frenguelli B, Morris RG. Dopaminergic modulation of the persistence of one-trial hippocampus-dependent memory. Learn Mem 2006, 13:760-769.
38. Paulus W, Trenkwalder C. Less is more: pathophysiology of dopaminergic-therapy-related augmentation in restless legs syndrome. Lancet Neurol 2006, 5:878-886.
39. Rothwell JC. Evoked potentials, magnetic stimulation studies, and event-related potentials. Curr Opin Neurol 1993, 6:715-723.
40. Seamans JK, Yang CR. The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Prog Neurobiol 2004, 74:1-58.
41. Ueki Y, Mima T, Kotb MA, Sawada H, Saiki H, Ikeda A, Begum T, Reza F, Nagamine T, Fukuyama H. Altered plasticity of the human motor cortex in Parkinson's disease. Ann Neurol 2006, 59:60-71.
42. Volkow ND, Wang GJ, Fowler JS, Logan J, Schlyer D, Hitzemann R, Lieberman J, Angrist B, Pappas N, MacGregor R, Burr G, Cooper T, Wolf AP. Imaging endogenous dopamine competition with [11C]raclopride in the human brain. Synapse 1994, 16:255-262.
43. Yamada K, Furukawa T. Direct evidence for involvement of dopaminergic inhibition and cholinergic activation in yawning. Psychopharmacology (Berl) 1980, 67:39-43.
44. Williams GV, Castner SA. Under the curve: critical issues for elucidating D1 receptor function in working memory. Neuroscience 2006, 139:263-276.